Lilly Faces Triple Threat of Drug Pricing Pressure as CEO Emphasizes Value
From the price of forthcoming weight loss pill orforglipron, to Most Favored Nation drug pricing and the market battle with Novo Nordisk, pricing was the number one issue for Eli Lilly on its second quarter earnings call.
Lilly Faces Triple Threat of Drug Pricing Pressure as CEO Emphasizes Value Read More »
